Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,048,967
+$6,235,915 QoQ
Shares Held
3,529,748
+9.6% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. NUVB ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in NUVB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,048,967 | 3,529,748 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,813,052 | 3,219,826 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $34,132,446 | 3,809,425 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,327,897 | 629,162 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $408,799 | 209,641 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $181,918 | 103,363 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $471,439 | 177,233 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $615,940 | 268,970 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $945,089 | 323,661 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,329,786 | 365,326 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $729,284 | 482,970 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $319,024 | 238,079 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $482,928 | 268,294 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $842,370 | 507,452 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $585,956 | 305,186 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $457,963 | 204,448 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $433,378 | 133,759 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $265,135 | 50,406 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $437,418 | 51,461 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $160,012 | 16,098 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $348,211 | 37,402 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $449 | 43 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||